Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Hepatitis B × adefovir × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Hepatitis B 1 Carcinoma, Hepatocellular 1

Interventions

entecavir 8 Tenofovir 3 lenvatinib 2 Sorafenib 2 Lamivudine 2 tenofovir alafenamide 1 navitoclax 1 human papillomavirus vaccine, L1 type 16, 18 1 adefovir 1 Ultrasonography 1 Tumor Necrosis Factor-alpha 1 Tetanus Toxoid 1 Telbivudine 1 Standard of Care 1 Rapid Diagnostic Tests 1 Raltegravir Potassium 1 Practice Guidelines as Topic 1 Polymorphism, Genetic 1 Pneumococcal Vaccines 1 PHY 906 1 Nivolumab 1 Measles-Mumps-Rubella Vaccine 1 Hypothermia, Induced 1 Heptavalent Pneumococcal Conjugate Vaccine 1 Hepatitis B Vaccines 1 Enzyme-Linked Immunosorbent Assay 1 Engerix-B 1 Cyclophosphamide 1 Control Groups 1 Cholecalciferol 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00960518 2009-08-17

TACE

Tongji University

Phase 2 Unknown

Gastrointestinal

Hepatitis B, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon ⚡